Article
28 Sep 2021
A Look At AIA § 3(n)(2): Part Two Of A Two-Part Series On AIA § 3(n) Effective Filing Date Provisions
AUTHORS CONTENT
Article
26 Jul 2021
AIA § 3(n) Effective Filing Date Provisions Part I: A Look At PGR Eligibility
Article
19 Jul 2021
A Look At PGR Eligibility Under AIA § 3(n)(1): Part One Of A Two-Part Series On AIA §§ 3(n) Effective Filing Date Provisions
Article
17 Mar 2021
Fruit Of One's Label: A Review Of Three Key Federal Circuit Wins
Article
18 Aug 2020
Got Pharmaceutical Means-Plus-Function Claims?
Article
10 Jul 2020
Proposed Revisions To Form 3542 With Explanations
Article
14 Jan 2020
A Belated Lesson In How To Avoid A Finding Of Obviousness Based Upon Inherent Disclosure
Article
15 Oct 2019
The Boston Manifesto
Article
19 Jul 2019
The Amazing Story Of The Unsinkable Claim 8: How Many Lives Does A Patent Claim Have?
Article
19 Jul 2019
When Is A Broken Record Not A Broken Record?
Article
19 Jul 2019
Double The Trouble: Lack Of Priority Opens The Door To Unpatentability In An IPR Proceeding
Article
24 Jun 2019
A Tale Of Two Supplemental Examinations, Part II: Surprising Events When Citing Art That, But For A Clerical Error, Would Have Been Cited During Original Prosecution
Article
18 Jun 2019
A Tale Of Two Supplemental Examinations: Part 1: Unraveling Confusion
Article
07 Jun 2019
When Will They Ever Learn? Subject Matter Disclosed In The Patent Specification But Never Claimed Is Dedicated To The Public
Article
13 Mar 2019
Only Having The Pieces Of A Jigsaw Puzzle Isn't Enough - They Have To Be Assembled Together
Article
02 Jan 2019
Combine the Label with Phase III Clinical Results and a Carefully Crafted, Mirroring US Patent Application to Achieve Longer Patent Exclusivity for US Life Science Patents
Article
27 Feb 2018
Coming Full Circle From Seagate To Halo On Invalidity Opinions
Article
22 Sep 2014
Derivation: Possession Versus Conception
Article
19 Jul 2006
Demystifying IP Due Diligence